Kidney Transplantation from SARS-CoV-2-Infected Deceased Donors: Comfort or Caution in Contemporary Practice?
- PMID: 37939207
- PMCID: PMC10637449
- DOI: 10.2215/CJN.0000000000000325
Kidney Transplantation from SARS-CoV-2-Infected Deceased Donors: Comfort or Caution in Contemporary Practice?
Conflict of interest statement
T. Alhamad reports consultancy for CareDx, Natera, and Veloxis; research funding from Angion, CareDx, CSL Imagine, Eldon, Eurofins, and Natera; honoraria from CareDx, Sanofi, and Veloxis; personal fees from CareDx, Eurofins, Horizon, Natera, Sanofi, and Veloxis; advisory or leadership roles for CareDx, Europhines, Horizon, and QSANT; and speakers bureau for CareDx, Sanofi, and Veloxis. K.L. Lentine reports consultancy for CareDx, Inc., ownership interest in CareDx, Inc., and speakers bureau for Sanofi.
Figures
References
-
- American Society of Transplantation (AST) Infectious Disease Community of Practice (IDCOP). SARS-CoV-2: Recommendations and Guidance for Organ Donor Testing and Evaluation; 2023. Accessed August 28, 2023. https://www.myast.org/sites/default/files/Donor%20Testing%20Document1.18...
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
